GlassScriptPhysician profile
Dianna Yan
NPI 1710928411
$1,201.61
in general payments reported to CMS, 2019-2025
15 companies · $90.57 in 2025
The $90.57 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $441 · 2021: $107 · 2022: $53.80 · 2023: $34.88 · 2024: $146 · 2025: $90.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $272.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $160.69 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2020 | |
| Gilead Sciences, INC. | $120.00 | 2020 | |
| Mylan Pharmaceuticals INC. | $112.05 | 2020-2022 | |
| Inspire Medical Systems, INC. | $96.00 | 2024 | Inspire |
| Aerin Medical INC. | $90.57 | 2025 | |
| Merck Sharp & Dohme LLC | $86.51 | 2019 | |
| Lupin INC. | $83.64 | 2019-2020 | |
| Coopersurgical, INC. | $79.99 | 2020-2024 | Endosee |
| Smith+Nephew, INC. | $78.31 | 2019 | |
| Astellas Pharma US INC | $67.35 | 2023-2024 | Veozah, Myrbetriq |
| Radius Health, INC. | $57.02 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $17.97 | 2019 | |
| Evofem Biosciences, INC. | $14.81 | 2021 | |
| Myovant Sciences INC. | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dianna Yan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.